CD8A and cancer: In this study, we showed that epilepsy patients with loss of function DEPDC5 mutations had reduced peripheral CD8+ T cells whereas high DEPDC5 expression positively correlated with tumor infiltration of CD8+ T cells as well as overall cancer patient survival.